Sangamo Therapeutics, Inc. (SGMO)

NASDAQ: SGMO · IEX Real-Time Price · USD

0.540

+0.013 (2.55%)

At close: May 7, 2024, 4:00 PM

0.547

+0.007 (1.39%)

After-hours: May 7, 2024, 7:55 PM EDT

Sangamo Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1997
Revenue	176.23	111.3	110.7	118.19	102.43	84.45	36.57	19.39	39.54	45.87	Upgrade
Revenue Growth (YoY)	58.34%	0.54%	-6.34%	15.39%	21.29%	130.95%	88.60%	-50.96%	-13.80%	90.07%	Upgrade
Gross Profit	176.23	111.3	110.7	118.19	102.43	84.45	36.57	19.39	39.54	45.87	Upgrade
Selling, General & Admin	61.17	62.68	63.22	67.1	61.69	46.74	27.2	26.33	19.2	15.68	Upgrade
Research & Development	234.06	249.9	230.82	180.65	145.92	114.87	65.73	65.62	67.2	56.97	Upgrade
Other Operating Expenses	155.01	0	0	0	0	0	0	0	0	0	Upgrade
Operating Expenses	450.24	312.58	294.04	247.74	207.61	161.6	92.93	91.95	86.4	72.65	Upgrade
Operating Income	-274.01	-201.28	-183.34	-129.55	-105.18	-77.15	-56.36	-72.56	-46.86	-26.78	Upgrade
Other Expense / Income	-11.1	-9.43	-5.36	-8.9	-9.99	-8.82	-1.79	-0.89	-0.43	-0.36	Upgrade
Pretax Income	-262.9	-191.85	-177.98	-120.65	-95.19	-68.33	-54.57	-71.67	-46.43	-26.42	Upgrade
Income Tax	-5.07	0.43	0.31	0.35	0	0	0	-0.01	-5.72	0	Upgrade
Net Income	-257.83	-192.28	-178.29	-121	-95.19	-68.33	-54.57	-71.66	-40.7	-26.42	Upgrade
Shares Outstanding (Basic)	174	154	145	134	112	97	78	71	70	67	Upgrade
Shares Outstanding (Diluted)	174	154	145	134	112	97	78	71	70	67	Upgrade
Shares Change	13.02%	6.76%	7.53%	19.92%	15.65%	24.15%	10.67%	1.14%	4.08%	19.74%	Upgrade
EPS (Basic)	-1.48	-1.25	-1.23	-0.90	-0.85	-0.70	-0.70	-1.02	-0.58	-0.39	Upgrade
EPS (Diluted)	-1.48	-1.25	-1.23	-0.90	-0.85	-0.70	-0.70	-1.02	-0.58	-0.39	Upgrade
Free Cash Flow	-246	-243.8	-256.53	155.16	-165.08	-6.52	7.43	-66.62	-33.72	-5.68	Upgrade
Free Cash Flow Per Share	-1.41	-1.58	-1.77	1.15	-1.47	-0.07	0.10	-0.94	-0.48	-0.09	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-155.48%	-180.85%	-165.61%	-109.61%	-102.69%	-91.35%	-154.13%	-374.23%	-118.51%	-58.38%	Upgrade
Profit Margin	-146.30%	-172.76%	-161.05%	-102.37%	-92.93%	-80.91%	-149.23%	-369.58%	-102.94%	-57.59%	Upgrade
Free Cash Flow Margin	-139.59%	-219.05%	-231.73%	131.28%	-161.16%	-7.71%	20.31%	-343.57%	-85.28%	-12.37%	Upgrade
EBITDA	-240.71	-171.29	-160.34	-107.28	-85.58	-65.98	-53.07	-70.68	-45.44	-25.87	Upgrade
EBITDA Margin	-136.59%	-153.90%	-144.84%	-90.77%	-83.55%	-78.12%	-145.13%	-364.51%	-114.92%	-56.39%	Upgrade
Depreciation & Amortization	22.19	20.56	17.64	13.37	9.61	2.36	1.5	1	0.99	0.55	Upgrade
EBIT	-262.9	-191.85	-177.98	-120.65	-95.19	-68.33	-54.57	-71.67	-46.43	-26.42	Upgrade
EBIT Margin	-149.18%	-172.37%	-160.78%	-102.08%	-92.93%	-80.91%	-149.23%	-369.65%	-117.42%	-57.59%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).